SPY749.60−0.63%QQQ674.25−0.83%BTC/USD67,133.70−1.61%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

Bruker Corp

BRKRNASDAQ

Trade with Public

$61.59

1.262.09%

At close: Nov 13, 4:00 PM EST

$61.59

N/A

After Hours: 4:00 PM EST

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Bruker (BRKR) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Bruker (BRKR) stock.

Analyst Consensus — 13 Analysts

10Buy

2Hold

1Sell

# Analysts13

Latest Upgrades and Downgrades for Bruker Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Citigroup	Albert Hu	PT Raise	Neutral	$53→$64
—	Leerink Partners	Puneet Souda	PT Raise	Outperform	$80→$85
—	JP Morgan	Casey Woodring	Downgrade	Overweight→Neutral	$60
—	TD Cowen	Kyle Boucher	PT Raise	Hold	$60→$62
—	Barclays	Luke Sergott	PT Raise	Overweight	$58→$70
—	Guggenheim	Subbu Nambi	PT Raise	Buy	$70→$72
—	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$80
—	UBS	Dan Leonard	PT Raise	Neutral	$45→$65
—	Citigroup	Brendan Digan	PT Cut	Neutral	$60→$53
—	Citigroup	Patrick Donnelly	PT Raise	Neutral	$44→$60
—	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$70
—	Guggenheim	Subbu Nambi	PT Raise	Buy	$50→$70
—	Barclays	Luke Sergott	PT Raise	Overweight	$53→$60
—	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$65
—	Wolfe Research	Mike Polark	Assumes	Peer Perform	—
—	UBS	Dan Leonard	PT Raise	Neutral	$40→$45
—	Citigroup	Patrick Donnelly	PT Raise	Neutral	$40→$44
—	TD Cowen	Kyle Boucher	PT Raise	Hold	$43→$45
—	Barclays	Luke Sergott	PT Raise	Overweight	$45→$53
—	Barclays	Luke Sergott	PT Cut	Overweight	$50→$45

Bruker Corp

Bruker (BRKR) Stock Price Target 2026

Latest Upgrades and Downgrades for Bruker Stock

Bruker (BRKR) Stock Price Target 2026

Latest Upgrades and Downgrades for Bruker Stock

Analyst Ratings News

PRO
Citigroup Maintains Neutral on Bruker, Raises Price Target to $64

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

PRO
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PRO
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Citigroup Maintains Neutral on Bruker, Raises Price Target to $64

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

PRO
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PRO
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Bruker Corp

Bruker (BRKR) Stock Price Target 2026

Latest Upgrades and Downgrades for Bruker Stock

Bruker (BRKR) Stock Price Target 2026

Latest Upgrades and Downgrades for Bruker Stock

Analyst Ratings News

PROCitigroup Maintains Neutral on Bruker, Raises Price Target to $64

PROLeerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

PROJP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PROTD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PROBarclays Maintains Overweight on Bruker, Raises Price Target to $70

People Also Watch

People Also Watch

Analyst Ratings News

PROCitigroup Maintains Neutral on Bruker, Raises Price Target to $64

PROLeerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

PROJP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PROTD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PROBarclays Maintains Overweight on Bruker, Raises Price Target to $70

PRO
Citigroup Maintains Neutral on Bruker, Raises Price Target to $64

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

PRO
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PRO
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70

PRO
Citigroup Maintains Neutral on Bruker, Raises Price Target to $64

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $85

PRO
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

PRO
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70